Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
    March 2022
  1. CHUNG HC, Kang YK, Chen Z, Bai Y, et al
    Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
    Cancer. 2022;128:995-1003.
    >> Share

    July 2021
  2. LAU-MIN KS, Li Y, Eads JR, Wang X, et al
    Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice.
    Cancer. 2021;127:2562-2570.
    >> Share

    March 2021
  3. LEJA M, Kortelainen JM, Polaka I, Turppa E, et al
    Sensing gastric cancer via point-of-care sensor breath analyzer.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33437.
    >> Share

    February 2021
    Study adds evidence to link between gum disease and cancer risk: Researchers observe connection with gastric, esophageal cancer.
    Cancer. 2021;127:495-496.
    >> Share

    January 2021
  5. LI B, Cheung KS, Wong IY, Leung WK, et al
    Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory-wide study.
    Cancer. 2021 Jan 20. doi: 10.1002/cncr.33412.
    >> Share

    October 2020
  6. SETIA N, Wang CX, Lager A, Maron S, et al
    Morphologic and molecular analysis of early-onset gastric cancer.
    Cancer. 2020 Oct 13. doi: 10.1002/cncr.33213.
    >> Share

    June 2020

  7. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases.
    Cancer. 2020;126:2541-2546.
    >> Share

    February 2020
  8. SUH YS, Lee J, Woo H, Shin D, et al
    National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
    Cancer. 2020 Feb 7. doi: 10.1002/cncr.32753.
    >> Share

    January 2020
  9. TIAN S, Jiang R, Madden NA, Ferris MJ, et al
    Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Cancer. 2020;126:37-45.
    >> Share

    December 2019
  10. THIELS CA, Hanson KT, Habermann EB, Boughey JC, et al
    Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
    Cancer. 2019 Dec 10. doi: 10.1002/cncr.32660.
    >> Share

    July 2019
  11. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    >> Share

  12. CLEARY JM, Horick NK, McCleary NJ, Abrams TA, et al
    FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
    Cancer. 2019;125:2213-2221.
    >> Share

    June 2019
  13. GREALLY M, Agarwal R, Ilson DH
    Optimal management of gastroesophageal junction cancer.
    Cancer. 2019;125:1990-2001.
    >> Share

    May 2019
  14. SHARMA MR, Joshi SS, Karrison TG, Allen K, et al
    A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
    Cancer. 2019;125:1629-1636.
    >> Share

    March 2019
  15. HUANG J, Mo H, Zhang W, Chen X, et al
    Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China.
    Cancer. 2019;125:742-749.
    >> Share

    January 2019
  16. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016